Saliva: plasma concentration relationships for sulphapyridine following sulphasalazine administration to normal volunteers and patients with inflammatory bowel disease.
D003093:Colitis, Ulcerative / Q000378:metabolism*; D003424:Crohn Disease / Q000378:metabolism*; D006207:Half-Life; D006801:Humans; D007408:Intestinal Absorption; D007700:Kinetics; D008297:Male; D010641:Phenotype; D012463:Saliva / Q000378:metabolism*; D013424:Sulfanilamides / Q000378:metabolism*; D013427:Sulfapyridine / Q000097:blood / Q000378:metabolism*; D012460:Sulfasalazine / Q000097:blood / Q000378:metabolism*; D013997:Time Factors
D013424:Sulfanilamides; D012460:Sulfasalazine; D013427:Sulfapyridine